Barclays’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $664K | Buy |
155,840
+2,736
| +2% | +$11.7K | ﹤0.01% | 2889 |
|
|
2025
Q1 | $576K | Buy |
153,104
+38,225
| +33% | +$144K | ﹤0.01% | 2760 |
|
|
2024
Q4 | $669K | Buy |
114,879
+19,964
| +21% | +$116K | ﹤0.01% | 2885 |
|
|
2024
Q3 | $1.13M | Buy |
94,915
+48,614
| +105% | +$580K | ﹤0.01% | 2551 |
|
|
2024
Q2 | $501K | Buy |
46,301
+3,491
| +8% | +$37.8K | ﹤0.01% | 2538 |
|
|
2024
Q1 | $484K | Sell |
42,810
-586
| -1% | -$6.63K | ﹤0.01% | 2857 |
|
|
2023
Q4 | $609K | Buy |
43,396
+38,739
| +832% | +$544K | ﹤0.01% | 2895 |
|
|
2023
Q3 | $57K | Sell |
4,657
-695
| -13% | -$8.51K | ﹤0.01% | 3542 |
|
|
2023
Q2 | $48K | Buy |
5,352
+730
| +16% | +$6.55K | ﹤0.01% | 3692 |
|
|
2023
Q1 | $16K | Buy |
4,622
+714
| +18% | +$2.47K | ﹤0.01% | 4028 |
|
|
2022
Q4 | $9K | Sell |
3,908
-1,669
| -30% | -$3.84K | ﹤0.01% | 4152 |
|
|
2022
Q3 | $16K | Buy |
5,577
+1,749
| +46% | +$5.02K | ﹤0.01% | 4015 |
|
|
2022
Q2 | $16K | Sell |
3,828
-4,212
| -52% | -$17.6K | ﹤0.01% | 4178 |
|
|
2022
Q1 | $34K | Buy |
+8,040
| New | +$34K | ﹤0.01% | 4145 |
|